Paula Cloghessy
Plus aucun poste en cours
Fortune : 35 359 $ au 31/03/2024
Provenance du réseau au premier degré de Paula Cloghessy
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 22 | |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Joule Unlimited Technologies, Inc. produces renewable fuels and chemicals. It offers a technology platform for liquid fuel from the Sun. The company was founded by Noubar B. Afeyan in 2007 and is headquartered in Bedford, MA.
13
| Extinct | Industrial Specialties | 13 |
| Public Company | Biotechnology | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Paula Cloghessy via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PUBLIC SERVICE ENTERPRISE GROUP, INC. | Electric Utilities | Director of Finance/CFO | |
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Human Resources Officer Corporate Officer/Principal | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Chairman Corporate Officer/Principal | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member | |
River Vision Development Corp.
 River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Corporate Officer/Principal Graduate Degree | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Corporate Officer/Principal | |
| Boston University | College/University | Undergraduate Degree Doctorate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| INSEAD | College/University | Undergraduate Degree Masters Business Admin | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Doctorate Degree | |
| Worcester Polytechnic Institute | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Graduate Degree | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
The Energy Future Coalition
 The Energy Future Coalition Miscellaneous Commercial ServicesCommercial Services The Energy Future Coalition operates as a non-partisan alliance that seeks to bridge the differences among business, labor and environmental groups and identify energy policy options. It helps to educate and advocate energy generation and use. The company was founded in 2002 by Timothy E. Wirth, C. Boyden Gray and John D. Podesta and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Founder | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
The Russian Union of Industrialists & Entrepreneurs
 The Russian Union of Industrialists & Entrepreneurs Miscellaneous Commercial ServicesCommercial Services The Russian Union of Industrialists & Entrepreneurs operates as a non-political organization to protect the interests of industry. The company is based in Moscow, Russian Federation and has subsidiaries in the Russian Federation. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Agrinos AS
 Agrinos AS Chemicals: AgriculturalProcess Industries Agrinos AS engages in the development, production, and trade of biological crop inputs. Its products include iNvigorate, B-Sure, and Agrinos 5-0-0. The firm focuses on core crops such as corn, potatoes, soybeans, sugarcanes, tomatoes, and wheat; and regional crops such as verries, citrus and fruit trees, coffee, cotton, forage, leafy greens, and vegetables. The company was founded by Kjetil Langland Bøhn, Karl Reiner Fick Rochin, and Aaron Powers in 2009 and is headquartered in Oslo, Norway. | Chemicals: Agricultural | Chief Executive Officer Chief Executive Officer | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
| NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| IKENA ONCOLOGY, INC. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member | |
SYSTEMIQ Ltd.
 SYSTEMIQ Ltd. Investment ManagersFinance SystemIQ Ltd (SystemIQ ) is a venture capital firm founded by Martin Stuchtey and Jeremy Oppenheim in 2016. The firm Headquartered in United Kingdom. | Investment Managers | Consultant / Advisor | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| Edge Global LLC | Founder | ||
Beckman Consulting LLC
 Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Beckman Consulting LLC provides consulting services. The private company is based in Boston. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
| Sail Bio, Inc. | Director/Board Member Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 44 |
| Norvège | 3 |
| Japon | 2 |
| France | 2 |
| Russie | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 5 |
| Utilities | 2 |
Opérationnelle
| Director/Board Member | 216 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 68 |
| Chairman | 52 |
| Founder | 44 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jean-Francois Formela | 47 |
| Daniel Lynch | 32 |
| David Berry | 31 |
| Anatoliy Borisovich Chubays | 29 |
| Caroline Dorsa | 27 |
| Ruben Karlenovich Vardanian | 26 |
| Ronald Renaud | 24 |
| Owen Hughes | 23 |
| Brian Gallagher | 20 |
| Grégory Behar | 20 |
| Raffi Mardirosian | 18 |
| Claire Fraser-Liggett | 13 |
| Robert Meyer | 13 |
| E. Sutherland | 12 |
| George Demetri | 12 |
- Bourse
- Insiders
- Paula Cloghessy
- Connexions Sociétés
